Operating

Benefit from Receivables

Cardinal Health Benefit from Receivables increased by 8.3% to $13.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 18.8%, from $16.00M to $13.00M. Over 2 years (FY 2021 to FY 2025), Benefit from Receivables shows a downward trend with a -9.7% CAGR.

Analysis

StatementCash Flow Statement
SectionOperating
First reportedQ1 2014
Last reportedQ1 2026Oct 30, 2025
Metric ID: csco_benefit_from_receivables

Historical Data

14 periods
 Q4 '21Q1 '22Q2 '22Q1 '23Q3 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$16.00M$12.00M$47.00M$29.00M$58.00M$9.00M$19.00M$0.00$8.00M$16.00M$11.00M$14.00M$12.00M$13.00M
QoQ Change-25.0%+291.7%-38.3%+100.0%-84.5%+111.1%-100.0%+100.0%-31.3%+27.3%-14.3%+8.3%
YoY Change+141.7%-69.0%-100.0%+77.8%-42.1%+50.0%-18.8%
Range$0.00$58.00M
CAGR-6.2%
Avg YoY Growth+5.7%
Median YoY Growth-18.8%

Frequently Asked Questions

What is Cardinal Health's benefit from receivables?
Cardinal Health (CAH) reported benefit from receivables of $13.00M in Q3 2025.
How has Cardinal Health's benefit from receivables changed year-over-year?
Cardinal Health's benefit from receivables decreased by 18.8% year-over-year, from $16.00M to $13.00M.
What is the long-term trend for Cardinal Health's benefit from receivables?
Over 2 years (2021 to 2025), Cardinal Health's benefit from receivables has grown at a -9.7% compound annual growth rate (CAGR), from $65.00M to $53.00M.